Attached files

file filename
8-K - 8-K - LAM RESEARCH CORPd859764d8k.htm

Exhibit 99.1

FOR IMMEDIATE RELEASE

Lam Research Corporation Contact:

Audrey Charles, Investor Relations, phone: 510-572-1615, e-mail: audrey.charles@lamresearch.com

Lam Research Corporation Reports Financial Results for the Quarter Ended December 28, 2014

FREMONT, Calif., January 28, 2015 - Lam Research Corp. (NASDAQ: LRCX) today announced financial results for the quarter ended December 28, 2014 (the “December 2014 quarter”).

Highlights for the December 2014 quarter were as follows:

 

    Shipments of $1,247 million, up 12% from the prior quarter.

 

    Revenue of $1,232 million, up 7% from the prior quarter.

 

    GAAP gross margin of 43.6%, GAAP operating margin of 15.3% and GAAP diluted EPS of $1.00

 

    Non-GAAP gross margin of 45.4%, non-GAAP operating margin of 18.7%, and non-GAAP diluted EPS of $1.19

Lam Research Corporation

Financial Highlights for the Quarters Ended December 28, 2014 and September 28, 2014

(in thousands, except per share data and percentages)

 

GAAP

 
     December 2014     September 2014     Change Q/Q  

Revenue

   $ 1,232,241      $ 1,152,368        7%   

Gross margin as percentage of revenue

     43.6     43.9     -30 bps   

Operating margin as percentage of revenue

     15.3     14.6     70 bps   

Diluted EPS

   $ 1.00      $ 0.80        25%   

Non-GAAP

 
     December 2014     September 2014     Change Q/Q  

Revenue

   $ 1,232,241      $ 1,152,368        7%   

Gross margin as percentage of revenue

     45.4     45.8     -40 bps   

Operating margin as percentage of revenue

     18.7     18.0     70 bps   

Diluted EPS

   $ 1.19      $ 0.96        24%   

GAAP Financial Results

For the December 2014 quarter, revenue was $1,232.2 million, gross margin was $536.7 million, or 43.6% of revenue, operating expenses were $347.9 million, operating margin was 15.3% of revenue, and net income was $176.9 million, or $1.00 per diluted share on a GAAP basis. This compares to revenue of $1,152.4 million, gross margin of $505.5 million, or 43.9% of revenue, operating expenses of $337.2 million, operating margin of 14.6% of revenue, and net income of $141.1 million, or $0.80 per diluted share, for the quarter ended September 28, 2014 (the “September 2014 quarter”).

Non-GAAP Financial Results

For the December 2014 quarter, non-GAAP gross margin was $560.0 million or 45.4% of revenue, non-GAAP operating expenses were $330.2 million, non-GAAP operating margin was 18.7% of revenue, and non-GAAP net income was $207.6 million, or $1.19 per diluted share. This compares to non-GAAP gross margin of $528.0 million or 45.8% of revenue, non-GAAP operating expenses of $321.2 million, non-GAAP operating margin of 18.0% of revenue, and non-GAAP net income of $167.7 million, or $0.96 per diluted share for the September 2014 quarter.

“Lam’s December quarter concludes a record calendar year for the Company defined by outperformance in our industry and strong execution on our priorities,” said Martin Anstice, Lam Research’s president and chief executive officer. “For the year we grew revenue at twice the rate of the industry and made good progress on our market share objectives. Our strong execution combined with a meaningful market expansion is enabling a compelling multi-year growth opportunity.”

~more~

 

page 1 of 8


Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investment balances remained steady at $3.0 billion at the end of both the December 2014 quarter and the September 2014 quarter. Cash provided by operating activities was utilized for approximately $65.5 million of treasury stock purchases including net share settlement on employee stock-based compensation, $61.4 million of capital expenditures and $29.4 million of cash dividends paid to stockholders during the December 2014 quarter.

Deferred revenue at the end of the December 2014 quarter increased to $373.7 million as compared to $356.8 million at the end of the September 2014 quarter. Deferred profit at the end of the December 2014 quarter increased to $254.8 million as compared to $251.8 million at the end of the September 2014 quarter. Lam’s deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $53.2 million as of December 28, 2014.

Geographic Distribution

The geographic distribution of shipments and revenue during the December 2014 quarter is shown in the following table:

 

Region

   Shipments     Revenue  

Taiwan

     23     25

Korea

     30     24

United States

     16     18

Japan

     13     12

China

     7     8

Southeast Asia

     4     7

Europe

     7     6

Outlook

For the quarter ending March 29, 2015, Lam is providing the following guidance:

 

     GAAP    Reconciling
Items
     Non-GAAP

Shipments

   $1.45 Billion +/- $50 Million      —         $1.45 Billion +/- $50 Million

Revenue

   $1.37 Billion +/- $50 Million      —         $1.37 Billion +/- $50 Million

Gross margin

   42.5% +/- 1%    $ 21 Million       44.0% +/- 1%

Operating margin

   16.3% +/- 1%    $ 37 Million       19.0% +/- 1%

Earnings per share

   $1.06 +/- $0.07    $ 38 Million       $1.30 +/- $0.07

Diluted share count

   177 Million      3 Million       174 Million

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, financing arrangements, other investments, or other significant transactions that may be completed after the date of this release. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

 

    Gross margin - amortization related to intangible assets acquired in the Novellus transaction, $21 million.

 

    Operating margin - amortization related to intangible assets acquired in the Novellus transaction, $37 million.

 

    Earnings per share - amortization related to intangible assets acquired in the Novellus transaction, $37 million; amortization of convertible note discounts, $8 million; and associated tax benefit for non-GAAP items ($7) million; totaling $38 million.

 

    Diluted share count - impact of a note hedge issued contemporaneously with the convertible notes due in 2016 and 2018, 3 million shares.

Use of Non-GAAP Financial Results

In addition to GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the December 2014 and September 2014 quarters include the impact of the note hedge issued contemporaneously with the convertible notes due in 2016 and 2018 and exclude amortization related to intangible assets acquired in the Novellus transaction, the amortization of convertible note discounts, and tax expense (benefit) of non-GAAP items. Additionally, the December 2014 quarter non-GAAP results exclude acquisition-related inventory fair value adjustments, cost of restructuring and tax benefit on reinstatement of research and development credit. The September 2014 quarter non-GAAP results also exclude the rationalization of certain product configurations, gain associated with disposition of a business, and tax benefit on valuation allowance adjustment.

Management uses non-GAAP gross margin, operating income, operating expenses, operating margin, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to GAAP results are included at the end of this press release and on the Company’s web site at http://investor.lamresearch.com.

 

page 2 of 8


Lam Announces Financial Results for the December 2014 Quarter

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to, the anticipated revenue from shipments to Japanese customers; our ability to continue to outperform the semiconductor equipment industry; our ability to continue to grow our revenue and make progress on our market share objectives; our ability to execute and deliver performance that meets or exceeds our plans, including our abilities to execute on our priorities, and deliver multi-year growth; the scope of opportunities we have; our ability to expand our served market; the ability of the market to continue to expand and the extent of any such expansion; and our guidance for shipments, revenue, gross margin, operating margin, earnings per share, and diluted share count. Some factors that may affect these forward-looking statements include: business conditions in the consumer electronics industry, the semiconductor industry and the overall economy; the strength of the financial performance of our existing and prospective customers; the introduction of new and innovative technologies; the occurrence and pace of technology transitions and conversions; the actions of our competitors, consumers, semiconductor companies and key suppliers and subcontractors; and the success of research and development and sales and marketing programs. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks, including those detailed in documents filed by us with the Securities and Exchange Commission, including specifically our reports on Form 10-K for the year ended June 29, 2014 and Form 10-Q for the quarter ended September 28, 2014. These uncertainties and changes could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

About Lam Research

Lam Research Corp. (NASDAQ: LRCX) is a trusted global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam’s broad portfolio of market-leading deposition, etch, strip, and wafer cleaning solutions helps customers achieve success on the wafer by enabling device features that are 1,000 times smaller than a grain of sand, resulting in smaller, faster, and more power-efficient chips. Through collaboration, continuous innovation, and delivering on commitments, Lam is transforming atomic-scale engineering and enabling its customers to shape the future of technology. Based in Fremont, Calif., Lam Research is a NASDAQ-100 Index® and S&P 500® company whose common stock trades on the NASDAQ® Global Select Market™ under the symbol LRCX. For more information, please visit http://www.lamresearch.com. (LRCX-F)

Consolidated Financial Tables Follow.

###

 

page 3 of 8


Lam Announces Financial Results for the December 2014 Quarter

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data and percentages)

(unaudited)

 

     Three Months Ended     Six Months Ended  
     December 28,
2014
    September 28,
2014
    December 29,
2013
    December 28,
2014
    December 29,
2013
 

Revenue

   $ 1,232,241      $ 1,152,368      $ 1,116,061      $ 2,384,609      $ 2,131,120   

Cost of goods sold

     695,584        646,829        628,272        1,342,413        1,211,473   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

  536,657      505,539      487,789      1,042,196      919,647   

Gross margin as a percent of revenue

  43.6   43.9   43.7   43.7   43.2

Research and development

  196,768      188,934      174,477      385,702      345,044   

Selling, general and administrative

  151,148      148,307      148,838      299,455      304,721   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

  347,916      337,241      323,315      685,157      649,765   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

  188,741      168,298      164,474      357,039      269,882   

Operating margin as a percent of revenue

  15.3   14.6   14.7   15.0   12.7

Other expense, net

  (9,799   (5,648   (3,837   (15,447   (18,099
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

  178,942      162,650      160,637      341,592      251,783   

Income tax expense

  2,002      21,569      11,645      23,571      17,285   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

$ 176,940    $ 141,081    $ 148,992    $ 318,021    $ 234,498   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income per share:

Basic net income per share

$ 1.11    $ 0.87    $ 0.92    $ 1.98    $ 1.44   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted net income per share

$ 1.00    $ 0.80    $ 0.87    $ 1.80    $ 1.37   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Number of shares used in per share calculations:

Basic

  159,248      161,685      162,305      160,467      162,603   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

  177,046      177,118      171,757      177,082      171,592   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash dividend declared per share

$ 0.18    $ 0.18    $ —      $ 0.36    $ —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

 

page 4 of 8


Lam Announces Financial Results for the December 2014 Quarter

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

     December 28,
2014
     September 28,
2014
     June 29,
2014
 
     (unaudited)      (unaudited)      (1)  

ASSETS

        

Cash and cash equivalents

   $ 981,275       $ 1,293,678       $ 1,452,677   

Short-term investments

     1,902,402         1,593,668         1,612,967   

Accounts receivable, net

     944,014         864,403         800,616   

Inventories

     913,390         815,612         740,503   

Other current assets

     173,731         123,615         176,899   
  

 

 

    

 

 

    

 

 

 

Total current assets

  4,914,812      4,690,976      4,783,662   

Property and equipment, net

  585,372      555,658      543,496   

Restricted cash and investments

  155,455      149,483      146,492   

Goodwill and intangible assets

  2,282,006      2,322,153      2,360,303   

Other assets

  173,044      175,558      159,353   
  

 

 

    

 

 

    

 

 

 

Total assets

$ 8,110,689    $ 7,893,828    $ 7,993,306   
  

 

 

    

 

 

    

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities

$ 1,708,656    $ 1,599,625    $ 1,582,001   
  

 

 

    

 

 

    

 

 

 

Long-term debt, convertible notes, and capital leases

$ 830,880    $ 824,269    $ 817,202   

Income taxes payable

  205,535      217,118      258,357   

Other long-term liabilities

  183,678      179,711      122,662   
  

 

 

    

 

 

    

 

 

 

Total liabilities

  2,928,749      2,820,723      2,780,222   
  

 

 

    

 

 

    

 

 

 

Senior convertible notes

  181,505      182,432      183,349   

Stockholders’ equity (2)

  5,000,435      4,890,673      5,029,735   
  

 

 

    

 

 

    

 

 

 

Total liabilities and stockholders’ equity

$ 8,110,689    $ 7,893,828    $ 7,993,306   
  

 

 

    

 

 

    

 

 

 

 

(1) Derived from audited financial statements
(2) Common shares issued and outstanding were 159,294 shares as of December 28, 2014, 159,384 shares as of September 28, 2014 and 162,350 shares as of June 29, 2014.

 

page 5 of 8


Lam Announces Financial Results for the December 2014 Quarter

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

     Three Months Ended     Six Months Ended  
     December 28,
2014
    September 28,
2014
    December 29,
2013
    December 28,
2014
    December 29,
2013
 

CASH FLOWS FROM OPERATING ACTIVITIES:

          

Net income

   $ 176,940      $ 141,081      $ 148,992      $ 318,021      $ 234,498   

Adjustments to reconcile net income to net cash provided by operating activities:

          

Depreciation and amortization

     69,536        67,885        73,552        137,421        147,883   

Deferred income taxes

     3,320        3,186        12,457        6,506        12,457   

Impairment of long-lived asset

     —          —          628        —          7,632   

Equity-based compensation expense

     30,632        32,040        23,046        62,672        46,281   

Income tax benefit on equity-based compensation plans

     1,141        9,861        —          11,002        —     

Excess tax benefit on equity-based compensation plans

     (599     (10,404     —          (11,003     —     

Amortization of convertible note discount

     8,609        8,509        8,217        17,118        16,339   

Gain on sale of business

     —          (7,431     —          (7,431     —     

Other, net

     1,607        5,526        (2,428     7,133        1,687   

Changes in operating assets and liabilities:

     (129,947     (109,092     (135,441     (239,039     (285,829
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

  161,239      141,161      129,023      302,400      180,948   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

Capital expenditures and intangible assets

  (61,363   (41,871   (38,323   (103,234   (62,101

Cash paid for business acquisition

  —        (1,137   (18,388   (1,137   (18,388

Net sales/maturities (purchases) of available-for-sale securities

  (321,590   9,645      (88,754   (311,945   (46,187

Repayment of notes receivable

  3,978      —        10,000      3,978      10,000   

Proceeds from sale of business, net

  —        41,212      —        41,212      —     

Proceeds from sale of assets

  —        —        21,635      —        21,635   

Transfer of restricted cash and investments

  100      22      —        122      150   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash (used for) provided by investing activities

  (378,875   7,871      (113,830   (371,004   (94,891
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

Principal payments on long-term debt and capital lease obligations

  (674   (107   (719   (781   (807

Excess tax benefit on equity-based compensation plans

  599      10,404      —        11,003      —     

Treasury stock purchases

  (65,536   (308,422   (47,910   (373,958   (152,195

Dividends paid

  (29,381   (29,240   —        (58,621   —     

Reissuances of treasury stock related to employee stock purchase plan

  —        16,919      (35   16,919      15,119   

Proceeds from issuance of common stock

  4,223      4,609      8,449      8,832      21,023   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used for financing activities

  (90,769   (305,837   (40,215   (396,606   (116,860
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rate changes on cash

  (3,998   (2,194   1,393      (6,192   885   

Net decrease in cash and cash equivalents

  (312,403   (158,999   (23,629   (471,402   (29,918

Cash and cash equivalents at beginning of period

  1,293,678      1,452,677      1,156,184      1,452,677      1,162,473   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of period

$ 981,275    $ 1,293,678    $ 1,132,555    $ 981,275    $ 1,132,555   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

page 6 of 8


Lam Announces Financial Results for the December 2014 Quarter

Non-GAAP Financial Summary

(in thousands, except percentages and per share data)

(unaudited)

 

     Three Months Ended     Three Months Ended  
     December 28,
2014
    September 28,
2014
 
    

Revenue

   $ 1,232,241      $ 1,152,368   

Gross margin

   $ 560,044      $ 528,032   

Gross margin as percentage of revenue

     45.4     45.8

Operating expenses

   $ 330,213      $ 321,158   

Operating income

   $ 229,831      $ 206,874   

Operating margin as a percentage of revenue

     18.7     18.0

Net income

   $ 207,631      $ 167,671   

Net income per diluted share

   $ 1.19      $ 0.96   

Shares used in per share calculation - diluted

     174,316        175,433   

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and U.S. GAAP number of dilutive shares to Non-GAAP number of dilutive shares

(in thousands, except share and per share data)

(unaudited)

 

     Three Months Ended     Three Months Ended  
     December 28,
2014
    September 28,
2014
 
    

U.S. GAAP net income

   $ 176,940      $ 141,081   

Pre-tax non-GAAP items:

    

Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold

     21,286        20,893   

Costs associated with rationalization of certain product configurations - cost of goods sold

     —          1,600   

Acquisition-related inventory fair value impact - cost of goods sold

     2,101        —     

Amortization related to intangible assets acquired in Novellus transaction - operating expenses

     16,083        16,083   

Restructuring charges - operating expenses

     1,620        —     

Amortization of convertible note discount, Lam notes - other expense, net

     7,682        7,593   

Amortization of convertible note discount, Novellus assumed notes - other expense, net

     927        911   

Net gain associated with disposition of a business - other expense, net

     —          (4,331

Net tax (benefit) expense on non-GAAP items

     (7,914     (13,348

Net tax benefit on valuation allowance adjustment

     —          (2,811

Net tax benefit on reinstatement of research and development credit

     (11,094     —     
  

 

 

   

 

 

 

Non-GAAP net income

$ 207,631    $ 167,671   
  

 

 

   

 

 

 

Non-GAAP net income per diluted share

$ 1.19    $ 0.96   
  

 

 

   

 

 

 

U.S. GAAP number of shares used for diluted per share calculation

  177,046      177,118   

Effect of convertible note hedge

  (2,730   (1,685
  

 

 

   

 

 

 

Non-GAAP number of shares used for diluted per share calculation

  174,316      175,433   
  

 

 

   

 

 

 

 

page 7 of 8


Lam Announces Financial Results for the December 2014 Quarter

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income

(in thousands, except percentages)

(unaudited)

 

     Three Months Ended     Three Months Ended  
     December 28,
2014
    September 28,
2014
 

U.S. GAAP gross margin

   $ 536,657      $ 505,539   

Pre-tax non-GAAP items:

    

Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold

     21,286        20,893   

Costs associated with rationalization of certain product configurations - cost of goods sold

     —          1,600   

Acquisition-related inventory fair value impact - cost of goods sold

     2,101        —     
  

 

 

   

 

 

 

Non-GAAP gross margin

$ 560,044    $ 528,032   
  

 

 

   

 

 

 

U.S. GAAP gross margin as a percentage of revenue

  43.6   43.9

Non-GAAP gross margin as a percentage of revenue

  45.4   45.8

U.S. GAAP operating expenses

$ 347,916    $ 337,241   

Pre-tax non-GAAP items:

Amortization related to intangible assets acquired in Novellus transaction - operating expenses

  (16,083   (16,083

Restructuring charges - operating expenses

  (1,620   —     
  

 

 

   

 

 

 

Non-GAAP operating expenses

$ 330,213    $ 321,158   
  

 

 

   

 

 

 

Non-GAAP operating income

$ 229,831    $ 206,874   
  

 

 

   

 

 

 

Non-GAAP operating margin as a percent of revenue

  18.7   18.0

 

page 8 of 8